TECHNOLOGY PARTNERS
Technology Partners is a venture capital firm specialized in seed-, early-, and later-stage venture and private equity investments.
TECHNOLOGY PARTNERS
Industry:
Finance Financial Services Venture Capital
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Office 365 Mail Apache 2.4 Network Solutions DNS Comcast AppRiver
Similar Organizations
Converge
Converge is a venture capital firm that specializes in seed, startup, early Series A, and early-stage investments.
Current Employees Featured
Ted Ardell
Ted Ardell General Partner @ Technology Partners General Partner 1980-01-01
Marc van den Berg
Marc van den Berg General Partner @ Technology Partners General Partner 2012-04-01
Sheila Mutter
Sheila Mutter General Partner and CFO @ Technology Partners General Partner and CFO 1992-01-01
Ira Ehrenpreis
Ira Ehrenpreis General Partner @ Technology Partners General Partner 1996-01-01
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-01-07 | Benvenue Medical | Technology Partners investment in Series F - Benvenue Medical | 23 M USD |
2015-10-01 | Elcelyx Therapeutics | Technology Partners investment in Series E - Elcelyx Therapeutics | 40 M USD |
2015-08-16 | Beamreach | Technology Partners investment in Series D - Beamreach | 70 M USD |
2014-09-22 | Kaiam | Technology Partners investment in Venture Round - Kaiam | 35 M USD |
2014-07-21 | Beamreach | Technology Partners investment in Series D - Beamreach | 31 M USD |
2014-06-18 | Benvenue Medical | Technology Partners investment in Series E - Benvenue Medical | 40 M USD |
2014-04-16 | ForSight Labs | Technology Partners investment in Series C - ForSight Labs | 15 M USD |
2014-04-16 | ForSight VISION5 | Technology Partners investment in Series C - ForSight VISION5 | 15 M USD |
2014-04-02 | Transcend Medical | Technology Partners investment in Series C - Transcend Medical | 29 M USD |
2014-02-20 | Elcelyx Therapeutics | Technology Partners investment in Series C - Elcelyx Therapeutics | 24.72 M USD |